» Articles » PMID: 35708229

Complementary Structural Information for Antibody-Antigen Complexes from Hydrogen-Deuterium Exchange and Covalent Labeling Mass Spectrometry

Overview
Specialty Chemistry
Date 2022 Jun 16
PMID 35708229
Authors
Affiliations
Soon will be listed here.
Abstract

Characterizing antibody-antigen interactions is necessary for properly developing therapeutic antibodies, understanding their mechanisms of action, and patenting new drug molecules. Here, we demonstrate that hydrogen-deuterium exchange (HDX) mass spectrometry (MS) measurements together with diethylpyrocarbonate (DEPC) covalent labeling (CL) MS measurements provide higher order structural information about antibody-antigen interactions that is not available from either technique alone. Using the well-characterized model system of tumor necrosis factor α (TNFα) in complex with three different monoclonal antibodies (mAbs), we show that two techniques offer a more complete overall picture of TNFα's structural changes upon binding different mAbs, sometimes providing synergistic information about binding sites and changes in protein dynamics upon binding. Labeling decreases in CL generally occur near the TNFα epitope, whereas decreases in HDX can span the entire protein due to substantial stabilization that occurs when mAbs bind TNFα. Considering both data sets together clarifies the TNFα regions that undergo a decrease in solvent exposure due to mAb binding and that undergo a change in dynamics due to mAb binding. Moreover, the single-residue level resolution of DEPC-CL/MS can clarify HDX/MS data for long peptides. We feel that the two techniques should be used together when studying the mAb-antigen interactions because of the complementary information they provide.

Citing Articles

Mapping conformational changes on bispecific antigen-binding biotherapeutic by covalent labeling and mass spectrometry.

Shah A, Batabyal D, Qiu D, Cui W, Harrahy J, Ivanov A J Pharm Anal. 2024; 14(8):100966.

PMID: 39263356 PMC: 11388688. DOI: 10.1016/j.jpha.2024.100966.


Determination of Protein Monoclonal-Antibody Epitopes by a Combination of Structural Proteomics Methods.

Petrotchenko E, Nascimento E, Witt J, Borchers C J Proteome Res. 2023; 22(9):3096-3102.

PMID: 37526474 PMC: 10476242. DOI: 10.1021/acs.jproteome.3c00159.

References
1.
Houde D, Berkowitz S, Engen J . The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies. J Pharm Sci. 2011; 100(6):2071-86. PMC: 3164548. DOI: 10.1002/jps.22432. View

2.
Tremblay C, Kirsch Z, Vachet R . Epitope Mapping with Diethylpyrocarbonate Covalent Labeling-Mass Spectrometry. Anal Chem. 2021; 94(2):1052-1059. PMC: 8785103. DOI: 10.1021/acs.analchem.1c04038. View

3.
Rand K, Zehl M, Jensen O, Jorgensen T . Protein hydrogen exchange measured at single-residue resolution by electron transfer dissociation mass spectrometry. Anal Chem. 2009; 81(14):5577-84. DOI: 10.1021/ac9008447. View

4.
Liang S, Dai J, Hou S, Su L, Zhang D, Guo H . Structural basis for treating tumor necrosis factor α (TNFα)-associated diseases with the therapeutic antibody infliximab. J Biol Chem. 2013; 288(19):13799-807. PMC: 3650416. DOI: 10.1074/jbc.M112.433961. View

5.
Pan X, Limpikirati P, Chen H, Liu T, Vachet R . Higher-Order Structure Influences the Kinetics of Diethylpyrocarbonate Covalent Labeling of Proteins. J Am Soc Mass Spectrom. 2020; 31(3):658-665. PMC: 7077735. DOI: 10.1021/jasms.9b00132. View